Cite

HARVARD Citation

    Levy, A. et al. (n.d.). PO-0779 Current management of limited-stage SCLC and CONVERT trial impact: an EORTC LCG survey. Radiotherapy and oncology. pp. S402-S403. [Online]. 
  
Back to record